|
3 point MACE vs 5 point MACE
|
3
|
Resverlogix Corp.
|
Nov 02, 2018 09:44AM
|
|
About Makalu Fund
|
5
|
Resverlogix Corp.
|
Nov 02, 2018 10:37AM
|
|
Re: 3 point MACE vs 5 point MACE
|
2
|
Resverlogix Corp.
|
Nov 02, 2018 11:18AM
|
|
Re: 3 point MACE vs 5 point MACE
|
2
|
Resverlogix Corp.
|
Nov 02, 2018 02:19PM
|
|
Re: Pointing in the right direction & bogus Lilly
|
3
|
Resverlogix Corp.
|
Nov 03, 2018 12:11PM
|
|
MACE event rate
|
4
|
Resverlogix Corp.
|
Nov 03, 2018 12:42PM
|
|
Re: MACE event rate
|
2
|
Resverlogix Corp.
|
Nov 03, 2018 08:21PM
|
|
Re: MACE event rate
|
2
|
Resverlogix Corp.
|
Nov 05, 2018 10:56AM
|
|
Re: Resverlogix H2 2018 events
|
3
|
Resverlogix Corp.
|
Nov 05, 2018 12:56PM
|
|
3 point MACE in Phase 3 should be 10% percent lower than 4 point MACE in Phase 2's
|
5
|
Resverlogix Corp.
|
Nov 06, 2018 09:10AM
|
|
Re: Yahoo poster claims a reverse split coming....
|
1
|
Resverlogix Corp.
|
Nov 10, 2018 02:01PM
|
|
Re: AHA 2018 Resverlogix Poster #1
|
1
|
Resverlogix Corp.
|
Nov 12, 2018 10:23PM
|
|
Re: apabetalone and colorectal cancer
|
5
|
Resverlogix Corp.
|
Nov 13, 2018 01:01AM
|
|
Possible Zenith deal,..
|
4
|
Resverlogix Corp.
|
Nov 17, 2018 02:41PM
|
|
Re: Possible Zenith deal,..
|
2
|
Resverlogix Corp.
|
Nov 17, 2018 03:12PM
|
|
It almost looks like the stock is supported at the $3 CAD level
|
3
|
Resverlogix Corp.
|
Nov 19, 2018 10:24AM
|
|
If this trial were made up of ONLY placebo patients,..
|
1
|
Resverlogix Corp.
|
Nov 19, 2018 02:21PM
|
|
Re: If this trial were made up of ONLY placebo patients,..
|
1
|
Resverlogix Corp.
|
Nov 19, 2018 02:52PM
|
|
Re: Zenith and Pfizer collaboration news
|
1
|
Resverlogix Corp.
|
Nov 20, 2018 09:42AM
|
|
Re: Zenith and Pfizer collaboration news
|
2
|
Resverlogix Corp.
|
Nov 20, 2018 09:47AM
|
